Development of a more efficient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay

Clinical and Vaccine Immunology

Volumn 15, Issue 8, 2008, Pages 1304-1306

  Prince, Harry E ^a,b   Yeh, Cindy ^a   Lapé Nixon, Mary ^a  

^a Focus Diagnostics Inc   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ALGORITHM; ARTICLE; DENGUE; DENGUE VIRUS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELIABILITY;

ALGORITHMS; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOGLOBULIN M; MASS SCREENING;

EID: 49149115778     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00157-08     Document Type: Article

References (14)

1. Branch, S. L., and P. N. Levett. 1999. Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus. Clin. Diagn. Lab. Immunol. 6:555-557.
2. Centers for Disease Control and Prevention. 2007. Weekly dengue surveillance report. CDC Dengue Branch and Puerto Rico Department of Health. http://www.cdc.gov/ncidod/dvbid/dengue/documents/weeklyreport.pdf. Accessed 30 January 2008.
3. Chanama, S., S. Anantapreecha, A. A-nueggonpipat, A. Sa-gnasang, I. Kurane, and P. Sawanpanyalert. 2004. Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. J. Clin. Virol. 31:185-189.
4. Falconar, A. K. I., E. de Plata, and C. M. E. Romero-Vivas. 2006. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin. Vaccine Immunol. 13:1044-1051.
5. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-496.
6. Guzman, M. G., and G. Kouri. 1996. Advances in dengue diagnosis. Clin. Diagn. Lab. Immunol. 3:621-627.
7. Hayes, E. B., and D. J. Gubler. 1992. Dengue and dengue hemorrhagic fever. Pediatr. Infect. Dis. 11:311-317.
8. Hogrefe, W. R., R. Moore, M. Lape-Nixon, M. Wagner, and H. E. Prince. 2004. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J. Clin. Microbiol. 42:4641-4648.
9. Koraka, P., C. Suharti, T. E. Setiati, A. T. A. Mairuhu, E. Van Gorp, C. E. Hack, M. Juffrie, J. Sutaryo, G. M. Van Der Meer, J. Groen, and A. D. M. E. Osterhaus. 2001. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 39:4332-4338.
10. Levinson, S. S., and J. J. Miller. 2002. Toward a better understanding of heterophile (and the like) antibody interferences with modern immunoassays. Clin. Chim. Acta 325:1-15.
11. Pan American Health Organization. 2008. 2007: number of reported cases of dengue and dengue hemorrhagic fever (DHF), region of the Americas (by country and subregion). http://www.paho.org/English/AD/DPC/CD/dengue-cases-2007. htm. Accessed 30 January 2008.
12. Prince, H. E., and W. R. Hogrefe. 2003. Detection of West Nile virus (WNV)-specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States. Clin. Diagn. Lab. Immunol. 10:764-768.
13. Rawlins, M. L., E. M. Swenson, H. R. Hill, and C. M. Litwin. 2007. Evaluation of an enzyme immunoassay for detection of immunoglobulin M antibodies to West Nile virus and the importance of background subtraction in detecting nonspecific reactivity. Clin. Vaccine Immunol. 14:665-668.
14. Rigau-Perez, J. G., G. G. Clark, D. J. Gubler, P. Reiter, E. J. Sanders, and A. V. Vorndam. 1998. Dengue and dengue haemorrhagic fever. Lancet 352:971-977.